More than 1 in 4 U.S. adults struggle to afford their prescription medications. Those who can't are left with grim choices—such as skipping doses, cutting pills in half, or abandoning prescriptions ...

The bills will establish an advisory panel to examine data and ensure that federal drug pricing caps are applied to state-regulated health insurance plans if signed into law.

Adoption of the biosimilars at 1,541 hospitals increased from 18-37% in 2020 to 84-93% in 2024, coinciding with increased markup margins. The favorable impact on balance sheets resulted from a ...

An amendment to a bill on drug costs adds $31 million to restore eligibility to people in the AIDS Drug Assistance Program, but the House hasn't decided whether to support the move.

When it was passed in 1992, no one thought to mandate how hospitals and clinics would spend the deep discounts they receive on prescription drugs.

A federal judge handed down a decision this week in a lawsuit involving the 340B prescription drug discount program as hospitals, physicians, and drug manufacturers continue to battle over how the ...

The 340B drug program requires manufacturers to provide steep discounts for certain medications to safety net clinics, Federally Qualified Health Centers and other health care providers that serve low ...

Add Yahoo as a preferred source to see more of our stories on Google. Sen. Kannan Srinivasan, D-Loudoun, who sponsored a bill that originally would have mandated that pharmaceutical companies ...

After The New York Times reported in 2022 that a national hospital chain with roots in Virginia had taken advantage of a federal drug pricing program called 340B, federal lawmakers assembled a ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

AstraZeneca Pharmaceuticals LP, for now, must abide by a Hawaii law that requires it to deliver discounted drugs to pharmacies contracted to serve low-income individuals. Federal law doesn’t clearly ...

Hospital groups are asking HHS to give stakeholders more time to weigh in on a potential overhaul of the 340B drug pricing program, warning that the current 30-day comment period isn’t sufficient to ...